Articles in Press

Membership Campaign
Career Center
Navigating HEOR


Value in Health

Cover Image - Value in Health, Volume 24, Issue 12
Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Companion Journal

Value in Health Regional Issues is an online, MEDLINE/Pubmed-indexed journal that publishes articles on health-related topics that impact the health systems and health policies in the following regions: 1) Asia; 2) Central and Eastern Europe, Western Asia, and Africa; and 3) Latin America.



ISPOR—the professional society for health economics and outcomes research (HEOR)—is an international, multistakeholder, nonprofit organization. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the HEOR field.



Impact Factor
5th of 87
Health Policy & Services
7th of 102
Health Care Sciences & Services
19th of 371

Themed Sections

Value in Health showcases commissioned themed sections presenting original research and health policy articles specifically written to highlight contemporary topics. A full listing of themed sections published to date are here.


Most Read (Last 30 Days)

Most Cited (Previous 3 Years)